Interestingly, ROR expression levels are downregulated in tumor tissues of bladder cancer, breast cancer, colorectal cancer, gastric cancer, hepatocellular carcinoma, and cutaneous squamous cell carcinoma [3,37,69,76,88,89]. This evidence concerns the gene LINC-ROR and hepatocellular carcinoma.